Home > Boards > US OTC > Biotechs > Titan Pharmaceuticals Inc. (TTNP)

The preliminary data released Wednesday by the Centers

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
TRUTH Member Profile
Member Level 
Followed By 119
Posts 21,224
Boards Moderated 3
Alias Born 03/03/13
160x600 placeholder
Quarterly Report (10-q) Edgar (US Regulatory) - 8/16/2021 4:48:37 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/26/2021 5:18:30 PM
Titan Pharma reports positive TP-2021 implant results in animal model of chronic pruritus Seeking Alpha - 6/23/2021 8:32:57 AM
Titan Announces Positive Results from the First Studies of TP-2021 Implant in an Established Animal Model of Chronic Pruritus PR Newswire (US) - 6/23/2021 8:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/17/2021 4:13:01 PM
Titan Pharmaceuticals Announces Filing Of 2020 Annual Report On Form 10-K PR Newswire (US) - 3/31/2021 4:30:00 PM
Annual Report (10-k) Edgar (US Regulatory) - 3/31/2021 4:08:42 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/11/2021 6:38:07 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/11/2021 6:32:49 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/11/2021 6:27:46 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 2/8/2021 6:05:04 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/4/2021 2:25:04 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 2/4/2021 6:11:33 AM
Positive Early Study Results Help Pave Wave for Titan Pharmaceuticals to Move Forward with its JT-09 ProNeura® Development P... PR Newswire (US) - 2/1/2021 7:30:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 1/25/2021 8:26:40 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 1/22/2021 11:59:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 1/21/2021 2:29:19 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/19/2021 6:22:06 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 1/19/2021 6:12:48 AM
Titan Pharmaceuticals Announces Pricing of $9.7 Million Registered Direct Offering PR Newswire (US) - 1/15/2021 9:15:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/8/2021 4:16:11 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/7/2021 10:01:06 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/31/2020 6:01:23 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 12/31/2020 6:01:15 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/17/2020 6:02:05 AM
TRUTH Member Level  Thursday, 04/15/21 05:01:11 PM
Re: TRUTH post# 16840
Post # of 16845 
Quote:
The preliminary data released Wednesday by the Centers for Disease Control and Prevention show a 29 percent rise in overdose deaths from October 2019 through September 2020 — the most recent data available — compared with the previous 12-month period. Illicitly manufactured fentanyl and other synthetic opioids were the primary drivers, although many fatal overdoses have also involved stimulant drugs, particularly methamphetamine.

And unlike in the early years of the opioid epidemic, when deaths were largely among white Americans in rural and suburban areas, the current crisis is affecting Black Americans disproportionately.






TRUTH

I've never claimed to have all the answers but feel i'm beginning to corner the market in questions worthy of them.
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences